South Korea · Delayed Price · Currency is KRW Aprogen Medicines Statistics
Total Valuation
KRX:007460 has a market cap or net worth of KRW 71.95 billion. The enterprise value is 508.81 billion.
| Market Cap | 71.95B |
| Enterprise Value | 508.81B |
Important Dates
The last earnings date was Wednesday, May 27, 2026.
| Earnings Date | May 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
KRX:007460 has 21.04 million shares outstanding. The number of shares has increased by 12.19% in one year.
| Current Share Class | 21.04M |
| Shares Outstanding | 21.04M |
| Shares Change (YoY) | +12.19% |
| Shares Change (QoQ) | +0.20% |
| Owned by Insiders (%) | 6.78% |
| Owned by Institutions (%) | 3.42% |
| Float | 12.59M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.56 |
| PB Ratio | 0.17 |
| P/TBV Ratio | 1.00 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -6.94 |
| EV / Sales | 3.99 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -7.05 |
Financial Position
The company has a current ratio of 0.85, with a Debt / Equity ratio of 0.43.
| Current Ratio | 0.85 |
| Quick Ratio | 0.36 |
| Debt / Equity | 0.43 |
| Debt / EBITDA | n/a |
| Debt / FCF | -2.59 |
| Interest Coverage | -14.96 |
Financial Efficiency
Return on equity (ROE) is -32.72% and return on invested capital (ROIC) is -15.97%.
| Return on Equity (ROE) | -32.72% |
| Return on Assets (ROA) | -8.55% |
| Return on Invested Capital (ROIC) | -15.97% |
| Return on Capital Employed (ROCE) | -18.74% |
| Weighted Average Cost of Capital (WACC) | 3.26% |
| Revenue Per Employee | 498.20M |
| Profits Per Employee | -286.20M |
| Employee Count | 256 |
| Asset Turnover | 0.19 |
| Inventory Turnover | 1.54 |
Taxes
| Income Tax | -2.15B |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -66.32% in the last 52 weeks. The beta is 0.11, so KRX:007460's price volatility has been lower than the market average.
| Beta (5Y) | 0.11 |
| 52-Week Price Change | -66.32% |
| 50-Day Moving Average | 4,738.00 |
| 200-Day Moving Average | 8,746.23 |
| Relative Strength Index (RSI) | 38.18 |
| Average Volume (20 Days) | 1,647,506 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:007460 had revenue of KRW 127.54 billion and -73.27 billion in losses. Loss per share was -3,635.72.
| Revenue | 127.54B |
| Gross Profit | 31.55B |
| Operating Income | -93.70B |
| Pretax Income | -140.71B |
| Net Income | -73.27B |
| EBITDA | -70.41B |
| EBIT | -93.70B |
| Loss Per Share | -3,635.72 |
Balance Sheet
The company has 40.46 billion in cash and 187.09 billion in debt, with a net cash position of -146.63 billion or -6,969.68 per share.
| Cash & Cash Equivalents | 40.46B |
| Total Debt | 187.09B |
| Net Cash | -146.63B |
| Net Cash Per Share | -6,969.68 |
| Equity (Book Value) | 430.82B |
| Book Value Per Share | 6,833.55 |
| Working Capital | -29.99B |
Cash Flow
In the last 12 months, operating cash flow was -66.36 billion and capital expenditures -5.82 billion, giving a free cash flow of -72.18 billion.
| Operating Cash Flow | -66.36B |
| Capital Expenditures | -5.82B |
| Depreciation & Amortization | 23.29B |
| Net Borrowing | 41.35B |
| Free Cash Flow | -72.18B |
| FCF Per Share | -3,430.85 |
Margins
Gross margin is 24.74%, with operating and profit margins of -73.47% and -57.45%.
| Gross Margin | 24.74% |
| Operating Margin | -73.47% |
| Pretax Margin | -110.32% |
| Profit Margin | -57.45% |
| EBITDA Margin | -55.21% |
| EBIT Margin | -73.47% |
| FCF Margin | n/a |
Dividends & Yields
KRX:007460 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -12.19% |
| Shareholder Yield | -12.19% |
| Earnings Yield | -101.83% |
| FCF Yield | -100.32% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 14, 2026. It was a reverse split with a ratio of 0.0666666667.
| Last Split Date | Apr 14, 2026 |
| Split Type | Reverse |
| Split Ratio | 0.0666666667 |
Scores
KRX:007460 has an Altman Z-Score of -0.87 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.87 |
| Piotroski F-Score | 3 |